USPTO Examiner HORLICK KENNETH R - Art Unit 1637

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18942162METHOD OF SEQUENCING A NUCLEIC ACID OF INTERESTNovember 2024June 2025Allow720YesNo
18594336METHODS FOR MONITORING RESIDUAL DISEASEMarch 2024July 2024Allow410NoNo
18588765METHODS OF AMPLIFYING CIRCULAR POLYNUCLEOTIDES IN SITUFebruary 2024August 2024Allow620NoNo
18538986METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSDecember 2023August 2024Allow810NoNo
18535485METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSDecember 2023April 2024Allow410NoNo
18520939DNA Methylation Analysis to Identify Cell TypeNovember 2023June 2024Allow610NoNo
18491071METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSOctober 2023April 2024Allow610NoNo
18236540PROBE-BASED ANALYSIS OF NUCLEIC ACIDS AND PROTEINSAugust 2023January 2024Allow510NoNo
18448618METHODS FOR IDENTIFYING A LOCATION OF AN RNA IN A BIOLOGICAL SAMPLEAugust 2023February 2024Allow620NoNo
18226933METHODS, COMPOSITIONS, AND KITS FOR BLOCKING A CAPTURE PROBE ON A SPATIAL ARRAYJuly 2023October 2023Allow310NoNo
18219545METHODS FOR ANALYZING BIOLOGICAL SAMPLES IN A FLUIDIC DEVICE COMPRISING GENERATING A POLYMER MATRIX FROM PRECURSORS AT DISCRETE AREASJuly 2023January 2024Allow710YesNo
18333436SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATIONJune 2023September 2023Allow310NoNo
18317550METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSMay 2023August 2024Allow1510NoNo
18316870METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSMay 2023May 2024Allow1210YesNo
18316864METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSMay 2023August 2023Allow410NoNo
18307666FETAL SEX DETERMINATION USING CAPILLARY BLOOD FROM UPPER ARMApril 2023January 2024Allow920NoNo
18123235Method for the Analysis of Minimal Residual DiseaseMarch 2023August 2023Allow510YesNo
18186015METHODS FOR MULTIPLEX DETECTION OF POLYNUCLEOTIDES USING UNBOUND FLUORESCENT PROBES AND QUENCHER OLIGONUCLEOTIDESMarch 2023January 2024Allow1011YesNo
18181263METHODS, COMPOSITIONS, AND KITS FOR BLOCKING A CAPTURE PROBE ON A SPATIAL ARRAYMarch 2023July 2023Allow410NoNo
18176616NUCLEIC ACID CIRCULARIZATION AND AMPLIFICATION ON A SURFACEMarch 2023May 2024Allow1420YesNo
18166429COMPOSITIONS AND METHODS FOR PAIRWISE SEQUENCINGFebruary 2023August 2023Allow610NoNo
18157249SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATIONJanuary 2023August 2023Allow720NoNo
18061898METHODS AND SYSTEMS FOR ANALYZING NUCLEIC ACID MOLECULESDecember 2022December 2023Allow1210YesNo
17997174DEVICES AND METHODS FOR MULTI-DIMENSIONAL GENOME ANALYSISOctober 2022July 2023Allow910NoNo
17947984METHODS AND REAGENTS FOR NUCLEIC ACID ANALYSISSeptember 2022May 2023Allow810YesNo
17822117METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDESAugust 2022May 2024Allow2110NoNo
17890208UNIVERSAL SHORT ADAPTERS WITH VARIABLE LENGTH NON-RANDOM UNIQUE MOLECULAR IDENTIFIERSAugust 2022September 2023Allow1310NoNo
17814062METHODS AND COMPOSITIONS FOR SEQUENCING DOUBLE STRANDED NUCLEIC ACIDS USING RCA AND MDAJuly 2022January 2023Allow600YesNo
17869595METHODS, COMPOSITIONS, AND KITS FOR PREPARING NUCLEIC ACID LIBRARIESJuly 2022February 2024Allow1900NoNo
17812380COMPOSITIONS AND METHODS FOR RAPID IDENTIFICATION AND PHENOTYPIC ANTIMICROBIAL SUSCEPTIBILITY TESTING OF BACTERIA AND FUNGIJuly 2022January 2024Allow1810NoNo
17810696CHROMOPHORE-BASED DETECTION OF GENETIC VARIATIONS IN ANALYTESJuly 2022September 2023Allow1410NoNo
17810103METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSJune 2022November 2022Allow510NoNo
17809544METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSJune 2022November 2022Allow510NoNo
17825669METHOD OF DETECTING AND QUANTIFYING GENOMIC AND GENE EXPRESSION ALTERATIONS USING RNAMay 2022March 2023Allow1011NoNo
17738979DEVICES AND METHODS FOR ANTIBIOTIC SUSCEPTABILITY TESTINGMay 2022November 2023Allow1810NoNo
17719214METHODS OF SEQUENCING CIRCULAR TEMPLATE POLYNUCLEOTIDESApril 2022September 2022Allow510YesNo
17708981MATERIALS AND METHODS FOR LOCALIZED DETECTION OF NUCLEIC ACIDS IN A TISSUE SAMPLEMarch 2022March 2023Allow1110YesNo
17708169LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) BASED ASSAY FOR DETECTING MICROBESMarch 2022March 2024Allow2320YesNo
17696524SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATIONMarch 2022December 2022Allow920NoNo
17685964HIGHLY SENSITIVE METHODS FOR ACCURATE PARALLEL QUANTIFICATION OF NUCLEIC ACIDSMarch 2022July 2022Allow410NoNo
17637432METHOD FOR THE GENERATION OF DUMBBELL-SHAPED DNA VECTORSFebruary 2022June 2024Allow2810NoNo
17588089DIAGNOSIS AND TREATMENT OF INFLAMMATORY BOWEL DISEASEJanuary 2022May 2024Allow2811YesNo
17581285Integrated Device For Nucleic Acid Detection And IdentificationJanuary 2022January 2024Allow2420YesNo
17578296METHODS FOR INTERNALLY CONTROLLED IN SITU ASSAYS USING PADLOCK PROBESJanuary 2022April 2024Allow2700NoNo
17571360Sequencing Methods Using Improved Nucleotide Reagent SolutionsJanuary 2022August 2023Allow2010NoNo
17563781METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSDecember 2021July 2022Allow710NoNo
17563816METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSDecember 2021February 2023Allow1330YesNo
17558534METHODS AND SYSTEMS FOR DETECTING USUAL INTERSTITIAL PNEUMONIADecember 2021September 2023Allow2140YesNo
17543944RNA ISOLATION FROM SOLUBLE URINE FRACTIONSDecember 2021December 2023Allow2420NoNo
17530813METHODS FOR MULTIPLEX PCRNovember 2021April 2024Abandon2910YesNo
17526638ISOLATED OLIGONUCLEOTIDES CONTAINING MODIFIED NUCLEOTIDESNovember 2021September 2023Allow2210NoNo
17522741METHODS FOR PROCESSING NUCLEIC ACID SAMPLESNovember 2021February 2024Abandon2710NoNo
17521239COMPOSITIONS AND METHODS FOR PAIRWISE SEQUENCINGNovember 2021November 2023Allow2410NoNo
17513213PROCESS FOR THE ENZYMATIC SYNTHESIS AND AMPLIFICATION OF NUCLEIC ACIDSOctober 2021December 2023Abandon2510NoNo
17512587METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSOctober 2021August 2023Allow2110NoNo
17512581METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSOctober 2021August 2023Allow2110YesNo
17507373METHODS FOR ISOLATION OF CELL-FREE DNA USING AN ANTI-DOUBLE-STRANDED DNA ANTIBODYOctober 2021January 2023Allow1521NoNo
17497230SYSTEMS AND METHODS FOR COMBINED DETECTION OF GENETIC ALTERATIONSOctober 2021October 2023Allow2410NoNo
17600826DNA PROTECTION AGENT IN DNA IMAGING BUFFEROctober 2021May 2023Allow1910NoNo
17473760METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDESSeptember 2021April 2024Allow3110NoNo
17458162SELECTIVE AMPLIFICATION OF OVERLAPPING AMPLICONSAugust 2021October 2023Allow2610NoNo
17410903METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSAugust 2021March 2022Allow710NoNo
17407945SINGLE CELL SEQUENCINGAugust 2021June 2023Allow2110NoNo
17403537DETECTION OF GENE FUSIONS BY INTRAGENIC DIFFERENTIAL EXPRESSION (IDE) USING AVERAGE CYCLE THRESHOLDSAugust 2021October 2023Allow2620NoNo
17396171METHODS FOR HIGH LEVEL MULTIPLEXED POLYMERASE CHAIN REACTIONS AND HOMOGENEOUS MASS EXTENSION REACTIONSAugust 2021July 2023Allow2310NoNo
17386338SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATIONJuly 2021February 2022Allow710NoNo
17377284COMPOSITIONS AND METHODS FOR PAIRWISE SEQUENCINGJuly 2021October 2021Allow310YesNo
17370836MUTATION DETECTION ASSAYJuly 2021August 2023Allow2510NoNo
17370941SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATIONJuly 2021February 2022Allow710NoNo
17368276METHODS FOR IDENTIFYING A LOCATION OF AN RNA IN A BIOLOGICAL SAMPLEJuly 2021July 2023Allow2510NoNo
17312998METHOD OF NUCLEIC ACID ENRICHMENT USING SITE-SPECIFIC NUCLEASES FOLLOWED BY CAPTUREJune 2021June 2022Allow1210NoNo
17300304METHOD OF ANALYZING NUCLEIC ACID TEMPLATES USING RAPID LAMPMay 2021September 2023Abandon2810NoNo
17329844MULTIPLE AMPLIFICATION CYCLE DETECTIONMay 2021December 2023Allow3020NoNo
17326844Compositions Including A Double Stranded Nucleic Acid Molecule And A Stem-Loop OligonucleotideMay 2021September 2023Abandon2820NoNo
17244000METHODS FOR FAST NUCLEIC ACID AMPLIFICATIONApril 2021July 2023Allow2710NoNo
17238016METHODS FOR MULTIPLEX PCRApril 2021October 2021Allow510NoNo
17302030TCR/BCR Profiling Using Enrichment With Pools of Capture ProbesApril 2021March 2022Allow1110NoNo
17236743DROPLET TAGGING CONTIGUITY PRESERVED TAGMENTED DNAApril 2021February 2023Allow2210NoNo
17225659THREE-DIMENSIONAL SPATIAL MOLECULAR INDEXINGApril 2021June 2024Allow3810NoNo
17225597COMPOSITION FOR IMPROVING MOLECULAR BARCODING EFFICIENCY AND USE THEREOFApril 2021September 2023Allow2910NoNo
17223565Methods and Systems for Detecting Biological ComponentsApril 2021September 2023Allow2920NoNo
17223718PURIFICATION OF NUCLEIC ACIDS USING COPPER-TITANIUM OXIDESApril 2021November 2022Allow1910NoNo
17209957DIRECT QUANTIFICATION OF UNPROCESSED NUCLEIC ACID SAMPLESMarch 2021January 2023Allow2110YesNo
17209229IMMUNE PROFILING USING SMALL VOLUME BLOOD SAMPLESMarch 2021April 2023Allow2411NoNo
17209602PCR REACTION VESSEL, PCR DEVICE, AND PCR METHODMarch 2021July 2023Allow2810NoNo
17210191SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATIONMarch 2021February 2024Allow3520NoNo
17208538METHODS FOR NEXT GENERATION GENOME WALKING AND RELATED COMPOSITIONS AND KITSMarch 2021June 2023Allow2711YesNo
17271215SET OF GENES FOR MOLECULAR CLASSIFYING OF MEDULLOBLASTOMA AND USE THEREOFFebruary 2021January 2022Allow1120YesNo
17267810SET OF GENES FOR BLADDER CANCER DETECTION AND USE THEREOFFebruary 2021March 2022Allow1430YesNo
17169609METHODS FOR CHARACTERIZING DNA SEQUENCE COMPOSITION IN A GENOMEFebruary 2021February 2023Allow2410NoNo
17167974METHODS AND SYSTEMS FOR DETECTING GENETIC VARIANTSFebruary 2021July 2021Allow510NoNo
17152529SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATIONJanuary 2021March 2021Allow210NoNo
17147826BEAD BEATING TUBE AND METHOD FOR EXTRACTING DEOXYRIBONUCLEIC ACID AND/OR RIBONUCLEIC ACID FROM MICROORGANISMSJanuary 2021December 2023Allow3511NoNo
17146986SINGLE CELL SEQUENCINGJanuary 2021July 2021Allow620NoNo
17146359SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATIONJanuary 2021March 2021Allow210NoNo
17140640METHOD FOR DETECTING ON-TARGET AND PREDICTED OFF-TARGET GENOME EDITING EVENTSJanuary 2021October 2023Allow3320NoNo
17139451DEVICES AND METHODS FOR ANTIBIOTIC SUSCEPTABILITY TESTINGDecember 2020November 2021Allow1111YesNo
17251923METHOD FOR DISCRIMINATING BETWEEN LIVE AND DEAD MICROBES IN A SAMPLEDecember 2020January 2024Abandon3710NoNo
17251451LINEAGE TRACING USING MITOCHONDRIAL GENOME MUTATIONS AND SINGLE CELL GENOMICSDecember 2020February 2024Allow3810NoNo
16973990METHOD AND DEVICE FOR DIGITAL PCR MEASUREMENTDecember 2020February 2024Allow3810NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HORLICK, KENNETH R.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
13
Examiner Affirmed
10
(76.9%)
Examiner Reversed
3
(23.1%)
Reversal Percentile
35.1%
Lower than average

What This Means

With a 23.1% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
39
Allowed After Appeal Filing
8
(20.5%)
Not Allowed After Appeal Filing
31
(79.5%)
Filing Benefit Percentile
23.8%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner HORLICK, KENNETH R - Prosecution Strategy Guide

Executive Summary

Examiner HORLICK, KENNETH R works in Art Unit 1637 and has examined 1,015 patent applications in our dataset. With an allowance rate of 69.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 29 months.

Allowance Patterns

Examiner HORLICK, KENNETH R's allowance rate of 69.1% places them in the 23% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by HORLICK, KENNETH R receive 1.61 office actions before reaching final disposition. This places the examiner in the 43% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HORLICK, KENNETH R is 29 months. This places the examiner in the 44% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +29.0% benefit to allowance rate for applications examined by HORLICK, KENNETH R. This interview benefit is in the 80% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 26.3% of applications are subsequently allowed. This success rate is in the 33% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 57.1% of cases where such amendments are filed. This entry rate is in the 79% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 1% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 48.0% of appeals filed. This is in the 10% percentile among all examiners. Of these withdrawals, 58.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 36.7% are granted (fully or in part). This grant rate is in the 33% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 5.5% of allowed cases (in the 90% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.3% of allowed cases (in the 46% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.